Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | TY-011 |
Synonyms | |
Therapy Description |
TY-011 inhibits Aurora kinase A and B, as well as KDR (VEGFR2), resulting in inhibition growth and angiogenesis in tumors (PMID: 27887633, PMID: 32187025). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TY-011 | Aurka Inhibitors 26 Aurkb Inhibitors 21 VEGFR2 Inhibitor 37 | TY-011 inhibits Aurora kinase A and B, as well as KDR (VEGFR2), resulting in inhibition growth and angiogenesis in tumors (PMID: 27887633, PMID: 32187025). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|